Voices
Danny Burke Introduces a New E-Learning Course on HR+/HER2- Breast Cancer
Danny Burke/LinkedIn

Danny Burke Introduces a New E-Learning Course on HR+/HER2- Breast Cancer

Danny Burke, CEO of ecancer, shared a post on LinkedIn:

“Our Latest Free E-Learning Course Is Now Available.

Our latest free, evidence-based e-learning course explores the role of CDK4/6 inhibitors in HR-positive/HER2-negative breast cancer.

The course covers:

  • Disease biology.
  • Clinical evidence.
  • Genomic testing.
  • Treatment pathways.
  • Case-based learning to support best practices in patient care.

Access the course today to strengthen your understanding of this rapidly evolving area of breast cancer treatment.”

Other articles about Breast Cancer on OncoDaily.

biomarkers Breast Cancer breast oncology cancer Cancer research cancer treatment Case-Based Learning CDK4/6 inhibitors clinical evidence clinical oncology Continuing Medical Education Danny Burke E-Learning ecancer evidence based medicine genomic testing healthcare education HER2-negative breast cancer HR positive breast cancer HR+/HER2- breast cancer medical education OncoDaily Oncology Oncology Education Oncology Innovation patient care personalized medicine Precision Oncology treatment pathways